Beaumont, J. L., Butt, Z., Baladi, J., Motzer, R. J., Haas, T., Hollaender, N., . . . Cella, D. (2011). Patient-Reported Outcomes in a Phase III Study of Everolimus Versus Placebo in Patients with Metastatic Carcinoma of the Kidney That Has Progressed on Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy. AlphaMed Press.
শিকাগো স্টাইলে সাইটেশনBeaumont, Jennifer L., Zeeshan Butt, Jeanfrancois Baladi, Robert J. Motzer, Tomas Haas, Norbert Hollaender, Andrea Kay, এবং David Cella. Patient-Reported Outcomes in a Phase III Study of Everolimus Versus Placebo in Patients With Metastatic Carcinoma of the Kidney That Has Progressed On Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy. AlphaMed Press, 2011.
এমএলএ সাইটেশনBeaumont, Jennifer L., et al. Patient-Reported Outcomes in a Phase III Study of Everolimus Versus Placebo in Patients With Metastatic Carcinoma of the Kidney That Has Progressed On Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy. AlphaMed Press, 2011.